GSK will provide up to $465 million and Avalon will provide up to $30 million from its recently raised Fund X. Avalon will also contribute its expertise in managing life science and biotech companies, and GSK will provide resources for drug development. GSK gets an option to buy each company once it has found a drug for clinical ...
↧